OXFORD BIOMEDICA PLC (OXBDF:OTCMKTS)
$6.38 0.49 (8.3192%)
Analysed OXFORD BIOMEDICA PLC (OXBDF:OTCMKTS) News Sources
OXB expands US footprint with acquisition of commercial-scale viral vector facility in North Carolina
07-10-2025
yahoo.com
OXB acquires commercial-scale viral vector facility in North Carolina for $4.5M
08-10-2025
yahoo.com
Gene Therapy Market Outlook 2026-2031, Featuring Profiles of REGENXBIO, Oxford Biomedica, Voyager Therapeutics and More
23-01-2026
yahoo.com
[Latest] Global Adeno Associated Virus Vector Manufacturing Market Size/Share Worth USD 9.87 Billion by 2035 at a 13.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Growth Rate, Value, SWOT Analysis)
03-02-2026
yahoo.com
Oxford Biomedica (LSE:OXB) Stock Sees Fair Value Cut After Analysts Lower Growth Assumptions
26-08-2026
yahoo.com
Panmure Liberum says OxfordBiomedica share fall overdone after Novartis and BMS pause trials
02-09-2026
proactiveinvestors.com
What is the current price of OXFORD BIOMEDICA PLC (OXBDF:OTCMKTS)?
The current price of OXFORD BIOMEDICA PLC (OXBDF:OTCMKTS) is $6.38.
OXFORD BIOMEDICA PLC (OXBDF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of OXFORD BIOMEDICA PLC (OXBDF:OTCMKTS) since the previous trading day is $0.49.
OXFORD BIOMEDICA PLC (OXBDF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of OXFORD BIOMEDICA PLC (OXBDF:OTCMKTS) since the previous trading day is 8.3192%.
What is the most recent average sentiment score for OXFORD BIOMEDICA PLC (OXBDF:OTCMKTS)?
The most recent average sentiment score for OXFORD BIOMEDICA PLC (OXBDF:OTCMKTS) is 63 out of 100.
What is the most recent average sentiment for OXFORD BIOMEDICA PLC (OXBDF:OTCMKTS)?
The most recent sentiment for OXFORD BIOMEDICA PLC (OXBDF:OTCMKTS) is .
SEC-8K** Filing Available For OXFORD BIOMEDICA PLC (OXBDF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.